Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Explore this paper's citation graph
Summary
Although high fever was associated with the development of ARDS, it was also associated with better outcomes among patients with ARDS and treatment with methylprednisolone may be beneficial for patients who develop ARDS.
- Type
- article
- Published
- 2020-03-13
- Cited by
- 7,536
- References
- 34
- Access
- Open access
- OpenAlex
- https://openalex.org/W3011610993
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:212693474
Keywords
Medicine, ARDS, Interquartile range, Pneumonia, Internal medicine
References
- Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
- Naïve T cell maintenance and function in human aging
- Lung pathology of fatal severe acute respiratory syndrome
- A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan
- T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
- Adaptive immune cells temper initial innate responses
- Body Temperature and Mortality in Patients with Acute Respiratory Distress Syndrome
- Significant Changes of Peripheral T Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome
- Multiple organ infection and the pathogenesis of SARS
- Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome
- Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.
- Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014
- A prediction rule to identify low-risk patients with community-acquired pneumonia.
- Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
- COVID‐19 hypothesis: Activated protein C for therapy of virus‐induced pathologic thromboinflammation
Cited by
- Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
- COVID-19 Patients: A Systematic Review and Meta-Analysis of Laboratory Findings, Comorbidities, and Clinical Outcomes Comparing Medical Staff versus the General Population
- Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study
- Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
- SARS-CoV-2 Infection and the Kidneys: An Evolving Picture.
- Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study
- Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
- Accelerated perineural invasion in colitis-associated cancer
- Lymphomatous Interstitial Nephritis Coexistent with Paraneoplastic Crescentic Membranoproliferative Glomerulonephritis in a Case of Mantle Cell Lymphoma
- Title of article: Comparison of Fellow Eye of Acute Primary Angle Closure and Phacomorphic Angle Closure.
- Clinical considerations for patients with diabetes in times of COVID-19 pandemic
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- Mitigating Risk of COVID-19 in Dialysis Facilities.
- Novel Coronavirus (COVID‐19) Epidemic: What Are the Risks for Older Patients?
- Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials.
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- COVID-19 Infection
- Corticosteroids for patients with acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials
- The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
- Risk Factors for ARDS and Progression to Death Among COVID-19 Patients
Related papers
- [Ventilatory strategy for ARDS].
- The clinical value of Angiopoietin 2 in prediction of the onset of acute respiratory distress syndrome
- COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study
- Comparing Clinical Outcomes of COVID-19 and Influenza-Induced Acute Respiratory Distress Syndrome: A Propensity-Matched Analysis
- Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study
- Influence of pulmonary and extra-pulmonary factors on prognosis of acute respiratory distress syndrome
- Nosocomial pneumonia during acute respiratory distress syndrome
- Nosocomial pneumonia during acute respiratory distress syndrome